Skip to main content
Top
Published in: Diabetologia 9/2014

01-09-2014 | Meta-analysis

Surrogate measures of insulin sensitivity vs the hyperinsulinaemic–euglycaemic clamp: a meta-analysis

Authors: Julia Otten, Bo Ahrén, Tommy Olsson

Published in: Diabetologia | Issue 9/2014

Login to get access

Abstract

Aims/hypothesis

We aimed to identify which surrogate index of insulin sensitivity has the strongest correlation with the reference measurement, the hyperinsulinaemic–euglycaemic clamp (HEC), to determine which surrogate measure should be recommended for use in large-scale studies.

Methods

A literature search (1979–2012) was conducted to retrieve all articles reporting bivariate correlations between the HEC and surrogate measures of insulin sensitivity (in fasting samples or during the OGTT). We performed a random effects meta-analysis for each surrogate measure to integrate the correlation coefficients of the different studies.

Results

The OGTT-based surrogate measures with the strongest pooled correlations (r) to the HEC were the Stumvoll metabolic clearance rate (Stumvoll MCR; r = 0.70 [95% CI 0.61, 0.77], n = 5), oral glucose insulin sensitivity (OGIS; r = 0.70 [0.57, 0.80], n = 6), the Matsuda index (r = 0.67 [0.61, 0.73], n = 19), the Stumvoll insulin sensitivity index (Stumvoll ISI; r = 0.67 [0.60, 0.72], n = 8) and the Gutt index (r = 0.65 [0.60, 0.69], n = 6). The fasting surrogate indices that correlated most strongly with the HEC and had narrow 95% CIs were the revised QUICKI (r = 0.68 [0.58, 0.77], n = 7), the QUICKI (r = 0.61 [0.55, 0.65], n = 35), the log HOMA-IR (r = −0.60 [−0.66, −0.53], n = 22) and the computer generated HOMA of insulin sensitivity (HOMA-%S; r = 0.57 [0.46, 0.67], n = 5).

Conclusions/interpretation

The revised QUICKI fasting surrogate measure appears to be as good as the OGTT-based Stumvoll MCR, OGIS, Matsuda, Stumvoll ISI and Gutt indices for estimating insulin sensitivity. It can therefore be recommended as the most appropriate index for use in large-scale clinical studies.
Appendix
Available only for authorised users
Literature
4.
go back to reference DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223PubMed DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223PubMed
5.
go back to reference Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG (1990) Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322:223–228PubMedCrossRef Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG (1990) Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322:223–228PubMedCrossRef
6.
go back to reference DeFronzo RA, Ferrannini E, Simonson DC (1989) Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387–395PubMedCrossRef DeFronzo RA, Ferrannini E, Simonson DC (1989) Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387–395PubMedCrossRef
7.
go back to reference Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA (2007) Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30:89–94PubMedCrossRef Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA (2007) Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30:89–94PubMedCrossRef
8.
go back to reference Bonora E, Targher G, Alberiche M et al (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23:57–63PubMedCrossRef Bonora E, Targher G, Alberiche M et al (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23:57–63PubMedCrossRef
9.
go back to reference Rupinski MT, Dunlap WP (1996) Approximating Pearson product-moment correlations from Kennall's tau and Spearman's rho. Educ Psychol Meas 56:419–429CrossRef Rupinski MT, Dunlap WP (1996) Approximating Pearson product-moment correlations from Kennall's tau and Spearman's rho. Educ Psychol Meas 56:419–429CrossRef
10.
go back to reference Stumvoll M, Mitrakou A, Pimenta W et al (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23:295–301PubMedCrossRef Stumvoll M, Mitrakou A, Pimenta W et al (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23:295–301PubMedCrossRef
11.
go back to reference Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539–548PubMedCrossRef Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539–548PubMedCrossRef
12.
13.
go back to reference Hedges LV, Vevea JL (1998) Fixed- and random-effects models in meta-analysis. Psychol Methods 3:486–504CrossRef Hedges LV, Vevea JL (1998) Fixed- and random-effects models in meta-analysis. Psychol Methods 3:486–504CrossRef
14.
go back to reference Hedges LV, Olkin I (1985) Statistical methods for meta-analysis. Academic, Orlando Hedges LV, Olkin I (1985) Statistical methods for meta-analysis. Academic, Orlando
15.
go back to reference Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101PubMedCrossRef Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101PubMedCrossRef
16.
go back to reference Macaskill P, Walter SD, Irwig L (2001) A comparison of methods to detect publication bias in meta-analysis. Stat Med 20:641–654PubMedCrossRef Macaskill P, Walter SD, Irwig L (2001) A comparison of methods to detect publication bias in meta-analysis. Stat Med 20:641–654PubMedCrossRef
17.
19.
go back to reference Vevea JL, Woods CM (2005) Publication bias in research synthesis: sensitivity analysis using a priori weight functions. Psychol Methods 10:428–443PubMedCrossRef Vevea JL, Woods CM (2005) Publication bias in research synthesis: sensitivity analysis using a priori weight functions. Psychol Methods 10:428–443PubMedCrossRef
20.
go back to reference DeFronzo RA, Soman V, Sherwin RS, Hendler R, Felig P (1978) Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding. J Clin Invest 62:204–213PubMedCentralPubMedCrossRef DeFronzo RA, Soman V, Sherwin RS, Hendler R, Felig P (1978) Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding. J Clin Invest 62:204–213PubMedCentralPubMedCrossRef
21.
go back to reference Bergman RN, Finegood DT, Ader M (1985) Assessment of insulin sensitivity in vivo. Endocr Rev 6:45–86PubMedCrossRef Bergman RN, Finegood DT, Ader M (1985) Assessment of insulin sensitivity in vivo. Endocr Rev 6:45–86PubMedCrossRef
22.
go back to reference Bokemark L, Froden A, Attvall S, Wikstrand J, Fagerberg B (2000) The euglycemic hyperinsulinemic clamp examination: variability and reproducibility. Scand J Clin Lab Invest 60:27–36PubMedCrossRef Bokemark L, Froden A, Attvall S, Wikstrand J, Fagerberg B (2000) The euglycemic hyperinsulinemic clamp examination: variability and reproducibility. Scand J Clin Lab Invest 60:27–36PubMedCrossRef
23.
go back to reference Karelis AD, Henry JF, Malita F et al (2004) Comparison of insulin sensitivity values using the hyperinsulinemic euglycemic clamp: 2 vs 3 hours. Diabetes Metab 30:413–414PubMedCrossRef Karelis AD, Henry JF, Malita F et al (2004) Comparison of insulin sensitivity values using the hyperinsulinemic euglycemic clamp: 2 vs 3 hours. Diabetes Metab 30:413–414PubMedCrossRef
24.
go back to reference Bastard JP, Vandernotte JM, Faraj M et al (2007) Relationship between the hyperinsulinemic-euglycaemic clamp and a new simple index assessing insulin sensitivity in overweight and obese postmenopausal women. Diabetes Metab 33:261–268PubMedCrossRef Bastard JP, Vandernotte JM, Faraj M et al (2007) Relationship between the hyperinsulinemic-euglycaemic clamp and a new simple index assessing insulin sensitivity in overweight and obese postmenopausal women. Diabetes Metab 33:261–268PubMedCrossRef
25.
go back to reference Piche ME, Lemieux S, Corneau L, Nadeau A, Bergeron J, Weisnagel SJ (2007) Measuring insulin sensitivity in postmenopausal women covering a range of glucose tolerance: comparison of indices derived from the oral glucose tolerance test with the euglycemic-hyperinsulinemic clamp. Metabolism 56:1159–1166PubMedCrossRef Piche ME, Lemieux S, Corneau L, Nadeau A, Bergeron J, Weisnagel SJ (2007) Measuring insulin sensitivity in postmenopausal women covering a range of glucose tolerance: comparison of indices derived from the oral glucose tolerance test with the euglycemic-hyperinsulinemic clamp. Metabolism 56:1159–1166PubMedCrossRef
26.
go back to reference Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470PubMedCrossRef Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470PubMedCrossRef
27.
go back to reference Antuna-Puente B, Disse E, Rabasa-Lhoret R, Laville M, Capeau J, Bastard JP (2011) How can we measure insulin sensitivity/resistance? Diabetes Metab 37:179–188PubMedCrossRef Antuna-Puente B, Disse E, Rabasa-Lhoret R, Laville M, Capeau J, Bastard JP (2011) How can we measure insulin sensitivity/resistance? Diabetes Metab 37:179–188PubMedCrossRef
28.
go back to reference Petrie JR, Morris AD, Dorrian CA, Small M, Connell JM (1997) Specific insulin assays, insulin sensitivity and blood pressure. QJM 90:465–475PubMedCrossRef Petrie JR, Morris AD, Dorrian CA, Small M, Connell JM (1997) Specific insulin assays, insulin sensitivity and blood pressure. QJM 90:465–475PubMedCrossRef
29.
go back to reference Mather KJ, Hunt AE, Steinberg HO et al (2001) Repeatability characteristics of simple indices of insulin resistance: implications for research applications. J Clin Endocrinol Metab 86:5457–5464PubMedCrossRef Mather KJ, Hunt AE, Steinberg HO et al (2001) Repeatability characteristics of simple indices of insulin resistance: implications for research applications. J Clin Endocrinol Metab 86:5457–5464PubMedCrossRef
30.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRef Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRef
31.
go back to reference Gumbiner B, van Cauter E, Beltz WF et al (1996) Abnormalities of insulin pulsatility and glucose oscillations during meals in obese noninsulin-dependent diabetic patients: effects of weight reduction. J Clin Endocrinol Metab 81:2061–2068PubMed Gumbiner B, van Cauter E, Beltz WF et al (1996) Abnormalities of insulin pulsatility and glucose oscillations during meals in obese noninsulin-dependent diabetic patients: effects of weight reduction. J Clin Endocrinol Metab 81:2061–2068PubMed
32.
go back to reference Polonsky KS, Given BD, Hirsch LJ et al (1988) Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med 318:1231–1239PubMedCrossRef Polonsky KS, Given BD, Hirsch LJ et al (1988) Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med 318:1231–1239PubMedCrossRef
33.
go back to reference Monzillo LU, Hamdy O (2003) Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr Rev 61:397–412PubMedCrossRef Monzillo LU, Hamdy O (2003) Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr Rev 61:397–412PubMedCrossRef
34.
go back to reference Gutt M, Davis CL, Spitzer SB et al (2000) Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures. Diabetes Res Clin Pract 47:177–184PubMedCrossRef Gutt M, Davis CL, Spitzer SB et al (2000) Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures. Diabetes Res Clin Pract 47:177–184PubMedCrossRef
35.
go back to reference Belfiore F, Iannello S, Volpicelli G (1998) Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels. Mol Genet Metab 63:134–141PubMedCrossRef Belfiore F, Iannello S, Volpicelli G (1998) Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels. Mol Genet Metab 63:134–141PubMedCrossRef
36.
go back to reference Cederholm J, Wibell L (1990) Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract 10:167–175PubMedCrossRef Cederholm J, Wibell L (1990) Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract 10:167–175PubMedCrossRef
37.
go back to reference Reaven GM, Moore J, Greenfield M (1983) Quantification of insulin secretion and in vivo insulin action in nonobese and moderately obese individuals with normal glucose tolerance. Diabetes 32:600–604PubMedCrossRef Reaven GM, Moore J, Greenfield M (1983) Quantification of insulin secretion and in vivo insulin action in nonobese and moderately obese individuals with normal glucose tolerance. Diabetes 32:600–604PubMedCrossRef
38.
go back to reference Kolterman OG, Gray RS, Griffin J et al (1981) Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. J Clin Invest 68:957–969PubMedCentralPubMedCrossRef Kolterman OG, Gray RS, Griffin J et al (1981) Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. J Clin Invest 68:957–969PubMedCentralPubMedCrossRef
39.
go back to reference Hollenbeck CB, Chen N, Chen YD, Reaven GM (1984) Relationship between the plasma insulin response to oral glucose and insulin-stimulated glucose utilization in normal subjects. Diabetes 33:460–463PubMedCrossRef Hollenbeck CB, Chen N, Chen YD, Reaven GM (1984) Relationship between the plasma insulin response to oral glucose and insulin-stimulated glucose utilization in normal subjects. Diabetes 33:460–463PubMedCrossRef
40.
go back to reference Perseghin G, Caumo A, Caloni M, Testolin G, Luzi L (2001) Incorporation of the fasting plasma FFA concentration into QUICKI improves its association with insulin sensitivity in nonobese individuals. J Clin Endocrinol Metab 86:4776–4781PubMedCrossRef Perseghin G, Caumo A, Caloni M, Testolin G, Luzi L (2001) Incorporation of the fasting plasma FFA concentration into QUICKI improves its association with insulin sensitivity in nonobese individuals. J Clin Endocrinol Metab 86:4776–4781PubMedCrossRef
41.
go back to reference Katz A, Nambi SS, Mather K et al (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402–2410PubMedCrossRef Katz A, Nambi SS, Mather K et al (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402–2410PubMedCrossRef
42.
go back to reference Cleland SJ, Petrie JR, Morris AD, Ueda S, Dorrian CA, Connell JM (1996) FIRI: a fair insulin resistance index? Lancet 347:770PubMedCrossRef Cleland SJ, Petrie JR, Morris AD, Ueda S, Dorrian CA, Connell JM (1996) FIRI: a fair insulin resistance index? Lancet 347:770PubMedCrossRef
43.
go back to reference McAuley KA, Williams SM, Mann JI et al (2001) Diagnosing insulin resistance in the general population. Diabetes Care 24:460–464PubMedCrossRef McAuley KA, Williams SM, Mann JI et al (2001) Diagnosing insulin resistance in the general population. Diabetes Care 24:460–464PubMedCrossRef
44.
go back to reference Li G, Pan X (1995) A new insulin-sensitivity index for epidemiological study. Chin Med J (Engl) 108:55–56 Li G, Pan X (1995) A new insulin-sensitivity index for epidemiological study. Chin Med J (Engl) 108:55–56
45.
go back to reference DeFronzo R, Deibert D, Hendler R, Felig P, Soman V (1979) Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes. J Clin Invest 63:939–946PubMedCentralPubMedCrossRef DeFronzo R, Deibert D, Hendler R, Felig P, Soman V (1979) Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes. J Clin Invest 63:939–946PubMedCentralPubMedCrossRef
46.
go back to reference Hanson RL, Pratley RE, Bogardus C et al (2000) Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 151:190–198PubMedCrossRef Hanson RL, Pratley RE, Bogardus C et al (2000) Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 151:190–198PubMedCrossRef
Metadata
Title
Surrogate measures of insulin sensitivity vs the hyperinsulinaemic–euglycaemic clamp: a meta-analysis
Authors
Julia Otten
Bo Ahrén
Tommy Olsson
Publication date
01-09-2014
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 9/2014
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-014-3285-x

Other articles of this Issue 9/2014

Diabetologia 9/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.